DNA Testing | Resolve Lifelong Worries in 2 Days | Domestic Private Lab
EN/KR

About seeDNA Medical Genetics Laboratory

Future health, constitution, talents, biological relationships including parentage, and ancestral roots—anxieties and questions that suddenly arise in life can be sorted out and clarified through DNA analysis, the blueprint of humans.

From genetic tests that reveal health risks, constitution, talents, and genetic ethnic makeup, to DNA tests that confirm biological relationships, and even Non-Invasive Prenatal Testing (NIPT) to check the risk of genetic disorders like Down syndrome in unborn babies, seeDNA Medical Genetics Laboratory leads you to definitive answers with essentially "a single analysis."

Sample collection can be completed at home, and results are delivered in as few as 2 days. As a PrivacyMark certified institution, we ensure strict information management, so you can face the results with peace of mind. Knowing the truth revealed by DNA gives you the power to take the next step and change your future.

Why not discover your "true self" from your DNA?

Tokyo Laboratory Internal View

We operate two of the world's top-class automated inspection systems, introduced utilizing the Tokyo Metropolitan Government's "Capital Investment Support Project for Breakthrough Business Promotion." This enables us to provide reports at the fastest speed and most affordable level in Japan. Furthermore, we are the only facility in Japan to have a system where fetal (child) and parent DNA are analyzed twice each in "separate rooms" and by "separate examiners." This strict double-checking system ensures high accuracy and reliability.

{t('lab_tour_img_alt')}

Company Information

Company Name
seeDNA INC.
English Name
seeDNA INC.
Features
  • 1. Developed Japan's first prenatal DNA testing in August 2016
  • 2. Genetic testing institution with one of the highest numbers of DNA testing records in Japan
  • 3. Over 60,000 individuals analyzed, with "0" DNA testing judgment errors
  • 4. World-class testing accuracy (10 times the international standard: 99.99%)
Representative Director
Kihan Tomigane
Business Hours
Mon-Sun 9:00-18:00 (Excluding holidays)
Business Description
Forensic testing, mail-order sales of DNA testing kits
◇Headquarters◇
〒121-0813 2F Takenotsuka Building, 3-10-1 Takenotsuka, Adachi-ku, Tokyo Phone: 03-6659-2997 / Fax: 03-6869-9446
Email Address
support@seedna.co.jp
Osaka Branch Office
〒540-0003 6F USAC Hoenzaka Building, 2-7-20 Morinomiya Chuo, Chuo-ku, Osaka City Phone: 06-6942-1130 / Fax: 06-6942-1211
Affiliated Societies

Association of Genetic Information (AGI)
AGI・{t('info_society_1')}ロゴ
The Medico-Legal Society of Japan
{t('info_society_2')}ロゴ
DNA Testing Association
{t('info_society_3')}ロゴ
The Molecular Biology Society of Japan
{t('info_society_4')}ロゴ

Major Clients
Individuals, Medical Institutions, Law Firms (Lawyers), Corporations Mass Media (TV, Newspapers)
Partner Banks
MUFG Bank Japan Post Bank
Qualified Invoice Issuer Registration Number
T1010803001630

Certifications

ISO9001 Certification

2022/12/7 * G-CERTI-JAPAN * IAS (International Accreditation Service) * IAF (International Accreditation Forum)

PrivacyMark Certification
2022/4/20 JIPDEC (Japan Information Processing Development Center)

Trademarks

(Trademark App 2022-037001)
2023/7/4 seeDNA
(Trademark App 2022-037002)
2023/7/4　seeDNA会社ロゴ

Patents

Patent 7331325
2023/8/23 Genetic analysis method capable of performing two or more types of tests
Patent 7121440
2022/8/18 Method for calculating the reliability value of a signal at a polymorphic locus

Awards and History

FY2025 Advanced Service Creation Support Project Using Digital Technology
2025/10/30 Tokyo Metropolitan Small and Medium Enterprise Support Center
Overseas Digital Marketing Support
2025/06/16 Tokyo Metropolitan Small and Medium Enterprise Support Center
Texas, USA Hands-on Support Program
2024/08/26 Tokyo Metropolitan Small and Medium Enterprise Support Center
FY2024 June Business Potential Evaluation Project
2024/07/03 Tokyo Metropolitan Small and Medium Enterprise Support Center
Digital Marketing Individual Support
2024/05/24 Tokyo Metropolitan Small and Medium Enterprise Support Center
FY2023 Adachi Ward Certification Acquisition Support Grant
2024/02/06 Adachi Ward
GENOMICS SOLUTIONS PROVIDER IN APAC 2023
2023/12/01 Life Science Review
FY2023 Tokyo Metropolitan SME Foreign Patent Application Cost Subsidy
2023/10/02 Tokyo Metropolitan Small and Medium Enterprise Support Center
Work-Life Balance Promotion Company
2023/08/01 Adachi Ward
Vibrant Workplace Creation Support Project
2023/07/25 Adachi Ward
FY2022 SME Overseas Application/Infringement Countermeasures Support Project Subsidy
2022/07/22 Japan External Trade Organization (JETRO)
Capital Investment Support Project for Breakthrough Business Promotion
2021/10/22 Tokyo Metropolitan Small and Medium Enterprise Support Center
New Product/New Business Development Subsidy Adoption
2019/09/18 Adachi Ward

Media Features

TBS "THE TIME,"
2025/9
Overseas Medical Journal "MEDICAL TRIBUNE"
2024/12
Weekly Magazine "Weekly SPA!"
2024/08
Science News "Life Sciences Review"
2024/01
Fuji TV "Miracle Experience! Unbelievable"
2023/11
Weekly Magazine "Bunshun"
2023/03
PR Magazine "Company NOW"
2021/03
Fuji TV "Sunday THE Real! 'I want to be a family again'"
2020/06
Mainichi Shimbun
2020/01
Fuji TV "Ladies Ariyoshi"
2019/02
Fuji TV "Honmadekka!? TV"
2019/02
Fuji TV "Mezamashi TV"
2018/08
Nihon Keizai Shimbun "Debate on prenatal testing - Ethics and women's rights"
2018/07
TV Asahi "Super J Channel"
2017/03
Image
Image
Image
Image
Image
Image

Frequently Asked Questions

Q.What kind of company is seeDNA Medical Genetics Laboratory?

A.
seeDNA Medical Genetics Laboratory (seeDNA INC.) is a specialized DNA testing and genetic testing institution headquartered in Adachi-ku, Tokyo. In 2016, we succeeded in developing Japan's first prenatal DNA testing and have over 60,000 DNA analysis records. We hold ISO9001 and PrivacyMark certifications and belong to four societies: the Medico-Legal Society of Japan, DNA Testing Association, the Molecular Biology Society of Japan, and the Association of Genetic Information (AGI).

Q.What certifications and patents does seeDNA Medical Genetics Laboratory hold?

A.
We have obtained two certifications: ISO9001 certification (obtained December 7, 2022, IAS/IAF certified) and PrivacyMark certification (obtained April 20, 2022, JIPDEC certified). We hold two patents: "Genetic analysis method capable of performing two or more types of tests" (Patent 7331325, August 23, 2023) and "Method for calculating the reliability value of a signal at a polymorphic locus" (Patent 7121440, August 18, 2022).

Q.What are the features of seeDNA's testing accuracy and quality control system?

A.
seeDNA achieves world-class testing accuracy (10 times the international standard: 99.99%). We operate two automated inspection systems introduced through the Tokyo Metropolitan Government's "Capital Investment Support Project for Breakthrough Business Promotion," and are the only facility in Japan equipped with a double-checking system where fetal (child) and parent DNA are analyzed twice each in separate rooms by separate examiners. Through this system, we maintain a record of zero judgment errors across over 60,000 analyses.

Q.How many awards and public support records does seeDNA have?

A.
We have over 13 records of public support and awards between 2019 and 2025. Major achievements include the "Capital Investment Support Project for Breakthrough Business Promotion" from the Tokyo Metropolitan SME Support Center (2021), JETRO's "SME Overseas Application/Infringement Countermeasures Support Project Subsidy" (2022), Life Science Review's "GENOMICS SOLUTIONS PROVIDER IN APAC 2023" (2023), and Adachi Ward's "Work-Life Balance Promotion Company" certification (2023).

Q.What media appearances has seeDNA made?

A.
We have over 14 major media appearances between 2017 and 2025. On TV, we have appeared on TBS "THE TIME," (2025), Fuji TV "Honmadekka!? TV," "Mezamashi TV," and "Miracle Experience! Unbelievable." We have been featured in newspapers such as the Nihon Keizai Shimbun (2018) and Mainichi Shimbun (2020), as well as magazines including the overseas medical journal "MEDICAL TRIBUNE" (2024) and "Life Sciences Review" (2024).

References